Zinc-reversible Antimicrobial Activity of Recombinant Calprotectin (migration Inhibitory Factor-related Proteins 8 and 14)
Overview
Authors
Affiliations
Recombinant calprotectin, consisting of 2 individual peptide chains also called migration inhibitory factor-related protein (MRP)-8 and MRP14, was tested for antimicrobial activity in a Candida albicans growth inhibition assay. Both chains contain HEXXH zinc-binding sites and might be expected to manifest zinc-reversible, antimicrobial activity similar to that of native calprotectin. When tested alone, neither MRP8 nor MRP14 showed activity in the Candida growth assay. A synthetic 20-amino acid peptide containing the HEXXH sequence of MRP14, along with a nearby HHH sequence, was also inactive in this assay. However, equimolar concentrations of MRP8 and MRP14 demonstrated a potent growth inhibitory effect that was reversible by 30 microM zinc. Truncated MRP14 (missing the C-terminal GHHHKPGLGEGTP tail) used in combination with MRP8 demonstrated zinc-reversible activity that was somewhat less than that with complete MRP14. These results suggest that intact calprotectin, consisting of a heterodimer of MRP8 and MRP14, is necessary to form a zinc-binding site capable of inhibiting microbial growth.
Iron Sequestration by Murine Calprotectin Induces Starvation Responses in .
Peet J, Phan A, Oglesby A, Nolan E ACS Infect Dis. 2024; 10(2):688-700.
PMID: 38261753 PMC: 11273327. DOI: 10.1021/acsinfecdis.3c00539.
Cetin E, Mazzarino M, Gonzalez-Mateo G, Kopytina V, Meran S, Fraser D Front Cell Infect Microbiol. 2023; 13:1285193.
PMID: 38094743 PMC: 10716465. DOI: 10.3389/fcimb.2023.1285193.
S100A9 is indispensable for survival of pneumococcal pneumonia in mice.
Ostermann L, Seeliger B, David S, Flasche C, Maus R, Reinboth M PLoS Pathog. 2023; 19(7):e1011493.
PMID: 37467233 PMC: 10355425. DOI: 10.1371/journal.ppat.1011493.
Fang X, Lian H, Liu S, Dong J, Hua X, Li W Inflamm Res. 2023; 72(7):1485-1500.
PMID: 37335321 DOI: 10.1007/s00011-023-01757-5.
Kitagori K, Oku T, Wakabayashi M, Nakajima T, Nakashima R, Murakami K Arthritis Res Ther. 2023; 25(1):76.
PMID: 37165399 PMC: 10170829. DOI: 10.1186/s13075-023-03057-z.